Background: Hyponatremia is common in cirrhosis and is associated with high mortality. In contrast, hypernatremia is less frequent and is typically caused by hypotonic fluid losses due to osmotic diuresis, increased insensible water losses, and reduced water intake, often associated with encephalopathy. Lactulose, commonly used for the management of hepatic encephalopathy (HE), sometimes paradoxically worsens the encephalopathy due to the development of dehydration and hypernatremia. Prompt identification of the cause of hypernatremia and slow correction of serum sodium is associated with improved short-term survival. Case Presentation: We report a case of acute on chronic liver failure with HE, who developed hypernatremia during hospital stay due to lactulose-induced diarrhoea that worsened his sensorium further. After adjusting the dose of lactulose and correcting hypernatremia, his encephalopathy improved, and he was subsequently discharged. Conclusion: Lactulose may cause hypernatremia, especially in cirrhosis patients with hepatic encephalopathy. Early identification of hypernatremia, along with its cause and slow correction of sodium, is associated with improved short-term survival in decompensated cirrhosis.
References
[1]
Bernardi, M. and Zaccherini, G. (2018) Approach and Management of Dysnatremias in Cirrhosis. Hepatology International, 12, 487-499. https://doi.org/10.1007/s12072-018-9894-6
[2]
Lizaola, B., Bonder, A., Tapper, E.B., Mendez-Bocanegra, A. and Cardenas, A. (2016) The Changing Role of Sodium Management in Cirrhosis. Current Treatment Options in Gastroenterology, 14, 274-284. https://doi.org/10.1007/s11938-016-0094-y
[3]
Vilstrup, H., Amodio, P., Bajaj, J., Cordoba, J., Ferenci, P., Mullen, K.D., et al. (2014) Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology, 60, 715-735. https://doi.org/10.1002/hep.27210
[4]
Nanji, A.A. and Lauener, R.W. (1984) Lactulose-Induced Hypernatremia. Drug Intelligence & Clinical Pharmacy, 18, 70-71. https://doi.org/10.1177/106002808401800114
[5]
Nelson, D.C. (1983) Hypernatremia and Lactulose Therapy. JAMA: The Journal of the American Medical Association, 249, 1295-1298. https://doi.org/10.1001/jama.1983.03330340037027
[6]
Qian, Q. (2019) Hypernatremia. Clinical Journal of the American Society of Nephrology, 14, 432-434. https://doi.org/10.2215/cjn.12141018
[7]
Bataille, S., Baralla, C., Torro, D., Buffat, C., Berland, Y., Alazia, M., et al. (2014) Undercorrection of Hypernatremia Is Frequent and Associated with Mortality. BMC Nephrology, 15, Article No. 37. https://doi.org/10.1186/1471-2369-15-37
[8]
Angeli, P., Wong, F., Watson, H. and Ginès, P. (2006) Hyponatremia in Cirrhosis: Results of a Patient Population Survey. Hepatology, 44, 1535-1542. https://doi.org/10.1002/hep.21412
[9]
Hakimian, S., Coukos, J., Lui, J., Guilarte-Walker, Y., Mathews, J.P. and Zacharias, I. (2017) Hypernatremia in ICU Patients with Hepatic Encephalopathy Is Associated with Worse Outcomes. American Journal of Gastroenterology, 112, S515-S517. https://doi.org/10.14309/00000434-201710001-00920
[10]
Warren, S.E., Mitas, J.A. and Swerdlin, A.H. (1980) Hypernatremia in Hepatic Failure. JAMA: The Journal of the American Medical Association, 243, 1257-1260. https://doi.org/10.1001/jama.1980.03300380037019